BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Ingredientpharm - ECPv6.18.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://ingredientpharm.com
X-WR-CALDESC:Events for Ingredientpharm
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Berlin
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261104
DTEND;VALUE=DATE:20261105
DTSTAMP:20261022T110954Z
CREATED:20261022T110954Z
LAST-MODIFIED:20261022T110954Z
UID:3120-1793750400-1793836799@ingredientpharm.com
SUMMARY:Cannabis Health Symposium 2026
DESCRIPTION:The Cannabis Health Symposium 2026 in Frankfurt offers a full‑day forum for clinicians\, researchers\, industry leaders and patient advocates. The meeting takes place on 4 November 2026 at Mainhaus and runs from 08:30 to 16:30. It focuses on Germany’s rapidly evolving medical cannabis landscape after the CanG reforms\, which reshaped prescribing pathways\, telemedicine access and patient demand. \nThe programme features twelve sessions and four panel debates\, covering evidence\, regulation\, prescribing practice\, pharmacy responsibilities\, reimbursement challenges and public‑health insights. Speakers address the state of the German market\, telemedicine debates\, pharmaceutical quality standards\, GMP and ASTM considerations\, women’s health\, chronic pain\, mental health and European market comparisons. \nThe symposium attracts healthcare professionals\, industry representatives and patient advocates\, creating a multidisciplinary environment. Clinicians join to understand prescribing pathways\, evidence and safeguards. Pharmacists attend to discuss product quality\, substitution issues and evolving responsibilities. Industry leaders participate to explore competition\, imports and regulatory trends. Researchers contribute public‑health data\, including EKOCAN findings on cannabis reform. \nVisitor numbers are not published\, but the event targets Germany’s largest medical cannabis network and includes 12 months of MCCS membership\, which signals strong professional engagement. \nThe symposium offers outstanding opportunities for networking and collaboration. Attendees gain direct access to decision‑makers shaping prescribing rules\, telemedicine standards and pharmacy practice. Moreover\, the event supports strategic dialogue between producers\, distributors and regulators. As Germany’s market grows\, participants can explore new business models\, clinical pathways and quality frameworks. These discussions help align industry innovation with clinical needs and regulatory expectations. \nKey industries represented include medical cannabis cultivation\, pharmaceutical manufacturing\, telemedicine providers\, pharmacy networks\, regulatory bodies and health‑data research. Their presence highlights the sector’s shift toward pharmaceutical rigor\, digital access and evidence‑based policy. Together\, these groups drive progress toward safer\, standardized and accessible cannabinoid medicines in Germany.
URL:https://ingredientpharm.com/event/cannabis-health-symposium-2026/
LOCATION:mainhaus Stadthotel Frankfurt\, Lange Strasse 26\, Frankfurt am Main\, 60311\, Germany
CATEGORIES:pharmaceutical
ATTACH;FMTTYPE=image/jpeg:https://ingredientpharm.com/wp-content/uploads/2026/10/Titelbild.jpg
ORGANIZER;CN="Job On Beauty":MAILTO:info@jobonbeauty.com
END:VEVENT
END:VCALENDAR